Orikine Bio Appoints Larry Edwards as Chairman of the Board  BARCELONA, Spain, January 20, 2026 / Biotech Newswire / -- Orikine Bio, a biotechnology company based at the Barcelona Science Park (PCB-UB ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously referred to as NAFLD, represents the most prevalent liver disorder globally, ...

Thymalin is a polypeptide complex derived from thymic preparations (often of bovine or calf origin), known to harbor among ...

The field of cancer immunotherapy has achieved remarkable progress, introducing strategies such as immune checkpoint inhibitors and adoptive cell therapies ...

Research led by the SickKids Research Institute in Toronto and the University of Pennsylvania, has found that immune-related ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

Explore how RPMI 1640 supports cancer and immunology research by providing essential nutrients for cell growth, metabolism, ...

Patients with chronic kidney disease (CKD) stage G3 showed distinct inflammatory cytokine profiles that correlated with disease progression. Specific cytokine clusters were associated with a faster ...

1T Cell Engineering, Mayo Clinic, Rochester, Minnesota. 2Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota. 3Department of ...

An illustration of two blue-hued T cells next to one another against a dark background. Regulatory T cells, or T regs, make up the basis for a slew of biotech companies working to treat immunological ...

With the newly approved indication for CRS, Avtozma IV now aligns with all approved indications for Actemra IV. CRS is a life-threatening condition in which an overactive immune response leads to the ...